Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation
Advanced Healthcare Materials · 2024-08 · 13 (20)
DOI: 10.1002/adhm.202400514 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 02.05.2024. Verfasst von Yilei Ma und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Life Sciences & Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou, 325035, China. Hauptthemen laut MEDLINE: Glioma, Nanoparticles, Cell Membrane, Tumor Microenvironment. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 154 Literaturangaben. Gefördert von: JinFeng Laboratory, Chongqing, China, Chongqing medical scientific research project.
Abstract (Originalsprache)
Gliomas, the most prevalent primary brain tumors, pose considerable challenges due to their heterogeneity, intricate tumor microenvironment (TME), and blood‐brain barrier (BBB), which restrict the effectiveness of traditional treatments like surgery and chemotherapy. This review provides an overview of engineered cell membrane technologies in glioma therapy, with a specific emphasis on targeted drug delivery and modulation of the immune microenvironment. This study investigates the progress in engineered cell membranes, encompassing physical, chemical, and genetic alterations, to improve drug delivery across the BBB and effectively target gliomas. The examination focuses on the interaction of engineered cell membrane‐coated nanoparticles (ECM‐NPs) with the TME in gliomas, emphasizing their potential to modulate glioma cell behavior and TME to enhance therapeutic efficacy. The review further explores the involvement of ECM‐NPs in immunomodulation techniques, highlighting their impact on immune reactions. While facing obstacles related to membrane stability and manufacturing scalability, the review outlines forthcoming research directions focused on enhancing membrane performance. This review underscores the promise of ECM‐NPs in surpassing conventional therapeutic constraints, proposing novel approaches for efficacious glioma treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Life Sciences & Biomedical Collaborative Innovation Center of Zhejiang Province, Wenzhou University, Wenzhou, 325035, China.
- Key Lab of Biohealth Materials and Chemistry of Wenzhou, Wenzhou University, Wenzhou, 325035, China.
- Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, 325000, China.
- Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, 400044, China.
- Chongqing Engineering Laboratory of Nano/Micro Biological Medicine Detection Technology, Chongqing University of Science and Technology, Chongqing, 401331, China.
- Chongqing Institute of Green and Intelligent Technology, Chinese Academy of Sciences, Chongqing, 400714, China.
ORCID-Profile: Jianshu Li, Haifeng Yang, Wei Wu, Da Sun
Förderung
- JinFeng Laboratory, Chongqing, China
- Chongqing medical scientific research project
Zitieren
APA
Ma, Y., Yi, J., Ruan, J., Ma, J., Yang, Q., Zhang, K., Zhang, M., Zeng, G., Jin, L., Huang, X., Li, J., Yang, H., Wu, W., & Sun, D. (2024). Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation. Advanced Healthcare Materials, 13(20). https://doi.org/10.1002/adhm.202400514
Vancouver
Ma Y, Yi J, Ruan J, Ma J, Yang Q, Zhang K, et al. Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation. Advanced Healthcare Materials. 2024;13(20). doi:10.1002/adhm.202400514
BibTeX
@article{Ma2024,
author = {Ma, Yilei and Yi, Jia and Ruan, Jing and Ma, Jiahui and Yang, Qinsi and Zhang, Kun and Zhang, Maolan and Zeng, Guoming and Jin, Libo and Huang, Xiaobei and Li, Jianshu and Yang, Haifeng and Wu, Wei and Sun, Da},
title = {Engineered Cell Membrane‐Coated Nanoparticles: New Strategies in Glioma Targeted Therapy and Immune Modulation},
journal = {Advanced Healthcare Materials},
year = {2024},
volume = {13},
number = {20},
doi = {10.1002/adhm.202400514}
}
EUVIMED